John P. Kenny is Chief Executive Officer of MERIDIAN BIOSCIENCE INC. Currently has a direct ownership of 0 shares of VIVO, which is worth approximately $0. The most recent transaction as insider was on Jan 31, 2023, when has been sold 267,651 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

John P. Kenny Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2023
SELL
Sale (or disposition) back to the issuer
-
267,651 Reduced 100.0%
0 Common Stock
Jan 31 2023
BUY
Grant, award, or other acquisition
-
47,060 Added 14.95%
267,651 Common Stock
Nov 04 2022
SELL
Payment of exercise price or tax liability
$136,714 $32.01 p/Share
4,271 Reduced 1.9%
220,591 Common Stock
Oct 03 2022
SELL
Payment of exercise price or tax liability
$1,269,682 $31.53 p/Share
40,269 Reduced 15.19%
224,862 Common Stock
Jun 27 2022
SELL
Open market or private sale
$1,867,070 $30.39 p/Share
61,437 Reduced 18.81%
265,131 Common Stock
Jun 27 2022
BUY
Exercise of conversion of derivative security
$620,514 $10.1 p/Share
61,437 Added 15.83%
326,568 Common Stock
Jun 24 2022
SELL
Open market or private sale
$406,770 $30.0 p/Share
13,559 Reduced 4.87%
265,131 Common Stock
Jun 24 2022
BUY
Exercise of conversion of derivative security
$136,946 $10.1 p/Share
13,559 Added 4.64%
278,690 Common Stock
Jun 23 2022
SELL
Open market or private sale
$598,281 $29.98 p/Share
19,956 Reduced 7.0%
265,131 Common Stock
Jun 23 2022
BUY
Exercise of conversion of derivative security
$245,459 $12.3 p/Share
19,956 Added 6.54%
285,087 Common Stock
Jun 22 2022
SELL
Open market or private sale
$1,327,028 $29.72 p/Share
44,651 Reduced 14.41%
265,131 Common Stock
Jun 22 2022
BUY
Exercise of conversion of derivative security
$647,440 $14.5 p/Share
44,651 Added 12.6%
309,782 Common Stock
Nov 15 2021
SELL
Other acquisition or disposition
-
155,511 Reduced 58.65%
109,620 Common Stock
Nov 15 2021
BUY
Grant, award, or other acquisition
-
155,511 Added 36.97%
265,131 Common Stock
Nov 04 2021
BUY
Grant, award, or other acquisition
-
56,472 Added 17.56%
265,131 Common Stock
Mar 17 2021
SELL
Open market or private sale
$750,000 $25.0 p/Share
30,000 Reduced 12.57%
208,659 Common Stock
Mar 10 2021
SELL
Open market or private sale
$250,000 $25.0 p/Share
10,000 Reduced 4.02%
238,659 Common Stock
Feb 16 2021
SELL
Open market or private sale
$71,596 $30.35 p/Share
2,359 Reduced 0.94%
248,659 Common Stock
Feb 16 2021
BUY
Exercise of conversion of derivative security
$21,028 $10.1 p/Share
2,082 Added 0.82%
251,018 Common Stock
Feb 12 2021
SELL
Open market or private sale
$789,095 $30.14 p/Share
26,181 Reduced 9.52%
248,936 Common Stock
Feb 12 2021
BUY
Exercise of conversion of derivative security
$233,280 $10.1 p/Share
23,097 Added 7.75%
275,117 Common Stock
Feb 11 2021
SELL
Open market or private sale
$39,600 $30.0 p/Share
1,320 Reduced 0.52%
252,020 Common Stock
Feb 11 2021
BUY
Exercise of conversion of derivative security
$11,756 $10.1 p/Share
1,164 Added 0.46%
253,340 Common Stock
Feb 08 2021
SELL
Open market or private sale
$2,039,080 $29.86 p/Share
68,288 Reduced 21.31%
252,176 Common Stock
Feb 08 2021
BUY
Exercise of conversion of derivative security
$813,448 $12.3 p/Share
66,134 Added 17.11%
320,464 Common Stock

Also insider at

QSI
Quantum-Si Inc Healthcare
BMRA
BIOMERICA INC Healthcare
JPK

John P. Kenny

Chief Executive Officer
Cincinnati, OH

Track Institutional and Insider Activities on VIVO

Follow MERIDIAN BIOSCIENCE INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIVO shares.

Notify only if

Insider Trading

Get notified when an Meridian Bioscience Inc insider buys or sells VIVO shares.

Notify only if

News

Receive news related to MERIDIAN BIOSCIENCE INC

Track Activities on VIVO